| Patents for C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027) |
|---|
| 03/05/2015 | US20150065440 Sulfated oligosaccharide derivatives |
| 03/03/2015 | US8969547 Method for preparing fluticasone furoate |
| 02/18/2015 | EP2836502A1 A NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3beta-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVER DISEASES AND ATHEROSCLEROSIS |
| 02/11/2015 | CN104350063A 疏水性治疗剂的制剂、其制备方法及应用 Hydrophobic therapeutic agent formulation, preparation method and application |
| 02/05/2015 | WO2015015246A1 Process for the preparation of abiraterone and abiraterone acetate |
| 02/05/2015 | WO2015014686A1 Process for the preparation of abiraterone or abiraterone acetate |
| 01/08/2015 | US20150011739 Tandem facial amphiphiles |
| 01/01/2015 | US20150005518 Process for alkynylating 16-substituted-17-keto steroids |
| 01/01/2015 | US20150005489 Process for the preparation of abiraterone and intermediates thereof |
| 12/17/2014 | CN104220450A 用于治疗代谢障碍、高脂血症、糖尿病、月旨肪肝疾病和动脉粥样硬化的新的胆固醇代谢物5-胆甾烯-3e，25-二醇二硫酸酯（25HCDS) For the treatment of metabolic disorders, hyperlipidemia, diabetes, fatty liver disease and aims month atherosclerosis new cholesterol metabolite 5- cholesteryl -3e, 25- glycol disulfate (25HCDS) |
| 12/09/2014 | US8906892 4-pregenen-11β-17-21-triol-3,20-dione derivatives |
| 10/21/2014 | US8865691 Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives |
| 09/23/2014 | US8841442 Process for preparing fluticasone propionate/furoate |
| 09/23/2014 | CA2637548C Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 09/11/2014 | US20140256932 Process for preparing 17-substituted steroids |
| 08/20/2014 | EP2766380A1 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| 08/13/2014 | CN103980336A 一种新的氟维司群的合成方法 A new method for the synthesis of fulvestrant in |
| 08/06/2014 | CN103965280A 一种氟维司群中间体的制备方法 Method for preparing fulvestrant intermediates |
| 08/05/2014 | US8796249 TGR5 modulators and methods of use thereof |
| 07/30/2014 | CN103958540A 神经活性类固醇、组合物、及其用途 Neuroactive steroids, compositions, and uses thereof |
| 07/17/2014 | US20140200341 Method for the Production of Fluoromethyl Esters of Androstan-17 beta Carboxylic Acids |
| 07/17/2014 | US20140200200 Antagonists of CB1 Receptor |
| 07/16/2014 | EP2753632A1 Neuroactive steroids, compositions, and uses thereof |
| 07/16/2014 | CN103923153A 一种<sup>14</sup>C标记的雌激素硫酸盐共轭物及其制备方法 One kind of <sup> 14 </ sup> C-labeled estrogen sulfate conjugates and its preparation method |
| 07/09/2014 | CN103910776A 一种螺内酯衍生物及其微生物转化制备方法与应用 Preparation and Application of a spironolactone derivatives and microbial transformation |
| 07/03/2014 | WO2014104400A1 Actinic-ray- or radiation-sensitive resin composition, actinic-ray- or radiation-sensitive film and method of forming pattern |
| 07/03/2014 | WO2014064712A3 An improved process for the preparation of fulvestrant |
| 07/02/2014 | CN102558273B 氟替卡松糠酸酯的制备方法 Preparation of fluticasone furoate |
| 06/25/2014 | CN103230417B 一种罗氏海盘车提取物在制备抗肿瘤药物中的应用 A Roche starfish extracts used in the preparation of antineoplastic |
| 05/30/2014 | WO2014079801A1 Method for increasing the particle size of crystalline active micro-particles |
| 05/29/2014 | US20140148593 Process for preparing fluticasone propionate/furoate |
| 05/29/2014 | US20140148428 Treatment of Pulmonary Disease |
| 05/22/2014 | WO2014075978A1 Process for the production of abiraterone-3-acetate involving an enol trliflation reaction in the presence of an alkoxy-pyridine compound |
| 05/22/2014 | US20140141247 Process for the preparation of fluticasone propionate form 1 |
| 05/15/2014 | WO2014071984A1 Process for making abiraterone-3-acetate |
| 05/14/2014 | CN103788164A 一种氟维司群的制备方法 Preparation method of fulvestrant in |
| 05/07/2014 | CN103781794A 用于生产雄甾烷-17-β-羧酸的氟甲基-酯的方法 For the production of androstane -17-β- acid fluoromethyl - method ester |
| 05/07/2014 | CN103772466A mTOR抑制剂及制备方法与在制备抗肿瘤药物中的应用 mTOR inhibitors and preparation method and application in the preparation of antineoplastic |
| 05/07/2014 | CN101679476B 23取代的胆汁酸作为tgr5调节剂及其使用方法 23 substituted bile acid as a modifier and the use tgr5 |
| 04/17/2014 | US20140107089 Structural modification of 19-norprogesterone i: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 04/09/2014 | EP2714711A1 Method for the production of fluoromethyl - esters of androstan- 17 - beta - carboxylic acids |
| 04/03/2014 | US20140094619 Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties |
| 04/03/2014 | US20140094443 TGR5 Modulators and Methods of Use Thereof |
| 02/27/2014 | US20140057886 Bile Acid Derivatives as FXR Ligands for the Prevention or Treatment of FXR-Mediated Diseases or Conditions |
| 02/19/2014 | EP2698375A2 TGR5 modulators and method of use thereof |
| 02/19/2014 | CN103588846A Preparation method of fluticasone propionate particles and applications of the particle |
| 02/18/2014 | CA2698172C Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties |
| 02/18/2014 | CA2654644C Novel process and intermediates |
| 02/13/2014 | US20140045808 Reducing Risk of Contracting Clostridium-Difficile Associated Disease |
| 12/18/2013 | CN103450310A Stigmasterol derivative and application thereof in preparation of anti-cancer drug |
| 11/14/2013 | WO2013169647A1 Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| 10/29/2013 | US8569276 Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 10/17/2013 | WO2013154752A1 A NOVEL CHOLESTEROL METABOLITE, 5-CHOLESTEN, 3β-25-DIOL, DISULFATE (25HCDS) FOR THERAPY OF METABOLIC DISORDERS, HYPERLIPIDEMIA, DIABETES, FATTY LIVER DISEASES AND ATHEROSCLEROSIS |
| 10/17/2013 | US20130274461 Method for preparing fluticasone furoate |
| 10/17/2013 | US20130274460 Electrophilic Reagents for Monohalomethylation, Their Preparation and Their Uses |
| 09/25/2013 | CN101870719B Organic functional compound having disulfide chemical bond and steroids skeleton, preparation method thereof and use thereof |
| 09/04/2013 | EP2632896A2 Electrophilic reagents for monohalomethylation,their preparation and their uses |
| 08/29/2013 | US20130225844 Method for Monofluoromethylation of Organic Substrates to Prepare Biologically Active Organic Compounds |
| 08/14/2013 | CN103249716A Electrophilic reagents for monohalomethylation,their preparation and their uses |
| 08/14/2013 | CN101654470B Intermediate used as anti-inflammatory androstane derivative compositions and uses thereof |
| 08/07/2013 | EP2623510A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and use thereof for treating diseases |
| 08/07/2013 | CN103230417A Use of Asterias rollestoni Bell extract in preparation of antitumor drug |
| 07/24/2013 | EP2616477A2 6-substituted demethyl-estradiol derivatives as er-beta agonists |
| 07/23/2013 | US8492570 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumor action |
| 07/17/2013 | CN101384610B Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 07/10/2013 | EP2611821A2 Process for preparing fluticasone propionate/furoate |
| 07/10/2013 | CN103193849A Preparation method of high-purity abiraterone acetate |
| 07/09/2013 | CA2606077C Polymorphic and amorphous salt forms of squalamine dilactate |
| 07/03/2013 | CN103183715A Furostan saponin derivative and purpose thereof |
| 06/18/2013 | US8466139 Formulation |
| 06/06/2013 | US20130143854 Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis |
| 05/16/2013 | US20130123223 4-pregenen-11beta-17-21-triol-3,20-dione derivatives |
| 05/07/2013 | CA2576922C Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 05/01/2013 | CN103073613A Synthesis method of fluticasone derivative |
| 04/25/2013 | US20130102577 Ship inhibitors and uses thereof |
| 04/23/2013 | CA2653552C Industrial process for the synthesis of 17.alpha.-acetoxy-11.beta.-[4-(n,n-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 04/18/2013 | WO2013056181A1 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| 04/18/2013 | CA2852057A1 3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| 04/11/2013 | US20130090468 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 04/10/2013 | EP2576584A1 Methods and compounds for the preparation of monofluoromethylated biologically active organic compounds |
| 04/10/2013 | EP2576583A1 Method for monofluoromethylation of organic substrates to prepare biologically active organic compounds |
| 04/10/2013 | CN103038244A Methods and compounds for the preparation of monofluoromethylated biologically active organic compounds |
| 04/10/2013 | CN103038243A Method for monofluoromethylation of organic substrates to prepare biologically active organic compounds |
| 03/27/2013 | CN102993259A Preparation method of fulvestrant intermediate |
| 03/21/2013 | US20130072698 Method and Compounds for the Preparation of Monofluoromethylated Biologically Active Organic Compounds |
| 03/14/2013 | WO2013036835A1 Neuroactive steroids, compositions, and uses thereof |
| 03/14/2013 | CA2848212A1 Neuroactive steroids, compositions, and uses thereof |
| 03/07/2013 | WO2011151624A8 Method for monofluoromethylation of organic substrates to prepare biologically active organic compounds |
| 01/22/2013 | CA2670773C 6-alkoxyalkyl estradiol derivatives and methods of use |
| 01/17/2013 | CA2840401A1 Process for the preparation of fluticasone propionate form 1 |
| 01/09/2013 | CN102863498A Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 12/27/2012 | US20120329766 Formulation |
| 12/25/2012 | US8338588 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 12/20/2012 | US20120321565 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist |
| 12/19/2012 | CN102827048A Intermediate of fulvestrant and preparation method and application thereof |
| 12/11/2012 | US8329680 Formulation |
| 11/29/2012 | WO2012160338A1 Method for the production of fluoromethyl - esters of androstan- 17 - beta - carboxylic acids |
| 11/28/2012 | EP2527355A2 Polymorphic and amorphous salt forms of squalamine dilactate |
| 11/14/2012 | CN101065394B process for the esterification of a carbothioic acid |
| 11/13/2012 | US8309713 Process for the preparation of 6-α,9-α-difluoro-17-α-((2-furanylcarbonyl)oxy)-11-β-hydroxy-16-α-methy1-3-oxo-androsta-1,4-diene-17-β- -carbothioic acid S-fluoromethyl |